Literature DB >> 7246346

In vivo formation of histamine phosphopyridoxal cyclic compounds.

D Kierska, K Sasiak, C Maśliński.   

Abstract

A possibility of in vivo formation of cyclic compounds between histamine (Hi) given i.p. and endogenous pyridoxal (PL) or pyridoxal 5'-phosphate (PLP) has been studied. Cyclic compounds of Hi with PL or PLP were found in all tissues examined. Although an increase in Hi levels in tissues enhances the formation of cyclic compounds, no simple relationship between the rate of formation and Hi concentration has been observed. The reaction seems to be limited by endogenous PLP. The cyclic products Hi-PL and Hi-PLP were discovered in urine. It is suggested that the process of cyclic compound formation may reduce PLP resources, resulting in a modification of PLP-enzyme activities.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7246346     DOI: 10.1007/bf01991450

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  13 in total

1.  Phosphopyridoxal complexes with histamine and histidine. (4) The kinetics of complex formation between histidine and pyridoxal 5' -phosphate in the presence of bacterial histidine decarboxylase.

Authors:  D Kierska; C Maśliński
Journal:  Agents Actions       Date:  1975-12

2.  Phosphopyridoxal complexes with histamine and histidine. (2) The influence of presumed complex on histidine decarboxylase activity in rat gastric mucosa.

Authors:  K Wohl; C Maśliński
Journal:  Agents Actions       Date:  1975-02

3.  Catecholamine receptors and cyclic AMP formation in the central nervous system: effects of tetrahydroisoquinoline derivatives.

Authors:  Y Nimitkitpaisan; P Skolnick
Journal:  Life Sci       Date:  1978-07-24       Impact factor: 5.037

4.  Occurrence of a new class of tetrahydroisoquinoline alkaloids in L-dopa-treated parkinsonian patients.

Authors:  C J Coscia; W Burke; G Jamroz; J M Lasala; J McFarlane; J Mitchell; M M O'Toole; M L Wilson
Journal:  Nature       Date:  1977-10-13       Impact factor: 49.962

5.  Tetrahydroisoquinolines derived from catecholamines or DOPA: effects on brain tyrosine hydroxylase activity.

Authors:  C D Weiner; M A Collins
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

6.  Phosphopyridoxal complexes with histamine and histidine. (5) The kinetics of cyclic compound formation between histamine and pyridoxal-5'-phosphate in the presence of pig kidney diamine oxidase and rat intestinal histaminase.

Authors:  K Sasiak; D Kierska; C Maśliński
Journal:  Agents Actions       Date:  1977-03

7.  An interaction between S-adenosyl-L-methionine and pyridoxal 5'-phosphate, and its effect on Saccharomyces cerevisiae.

Authors:  R W Trewyn; K D Nakamura; M L O'Connor; L W Parks
Journal:  Biochim Biophys Acta       Date:  1973-12-19

8.  Tetrahydronorharmane (tetrahydro-beta-carboline), a physiologically occurring compound of indole metabolism.

Authors:  H Honecker; H Rommelspacher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-11       Impact factor: 3.000

9.  Dopamine-derived tetrahydroisoquinoline alkaloids--inhibitors of neuroamine metabolism.

Authors:  A C Collins; J L Cashaw; V E Davis
Journal:  Biochem Pharmacol       Date:  1973-09-15       Impact factor: 5.858

10.  Phosphopyridoxal complexes with histamine and histidine. (1) The kinetics of complex formation between pyridoxal 5'-phosphate and histamine.

Authors:  D Kierska; K Sasiak; M Boguslawski; C Maśliński
Journal:  Agents Actions       Date:  1975-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.